3rd Annual Biologics Symposium - Preclinical | Copenhagen
Event Information
Description
We are proud to announce the next event in our series of free scientific symposia in Scandinavia! This event is focussed on the preclinical aspects of developing biologics and is being kindly hosted by Lundbeck in Valby.
A panel of industry experts will cover a wide range of topics related to preclinical aspects of biologics such as species selection, bioanalytical and toxicological aspects.
It will be a both educational and insightful day in Copenhagen and with plenty of time for questions and networking with peers. The event will run from 09:00 until 16:00 on the 14th of June in Copenhagen.
Space is limited so register today to secure your free place!
Agenda:
+ ”Bringing bispecific antibodies from idea to patients.” - Per Norlén, MD. PhD, Assoc. Prof - CEO - Alligator BioScience
+ ”Developing cell therapies.” - Dr. Alessandra De Riva - Principal Scientist - Envigo R&D
+ ”Assessing reproductive toxicity when developing mAbs” - Qikun Zhuand - Senior Toxicologist - Lundbeck and David Meyers, Reproductive Toxicologist - Envigo
+ ”Pre-clinical development of antibodies to alpha-synuclein for prevention of prion like seeding of protein aggregation in brain” - Pekka Kallunki - Principal Scientist - Lundbeck
+ ”Development of biologics - common issues when interacting with regulatory authorities .” - Jennifer Sims BSc, PhD, ERT - President at Integrated Biologix
Venue:
Lundbeck, Valby, Copenhagen have kindly agreed to again host the event.
Feedback from previous events:
“Many thanks for providing such a great workshop, I hope you will run more of these events in the future”
“The most focused symposium that I have attended in years”
“Very relevant and useful to my work, thank you for organising it”
What else do you need to know?
If there is anything else you need to know about the event before or after you have registered please feel free to contact us and we will endeavour to get you the information you need. Looking forward to meeting you all!
Morten Fjordholt
Director – Pharmaceutical Development
Morten.fjordholt@envigo.com
Will Stimpson
Director – CMC services
William.stimpson@envigo.com
